We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Map Reveals How Zika Virus Associates with Host Cell Proteins

By LabMedica International staff writers
Posted on 05 Sep 2018
A team of viral molecular biologists has mapped host cell protein interaction profiles for each of the ten polypeptides encoded in the Zika virus (ZIKV) genome, generating a protein topology network comprising 3033 interactions amongst 1224 unique human polypeptides.

Zika virus is a membrane enveloped Flavivirus with a positive strand RNA genome, transmitted by Aedes mosquitoes. More...
The geographical range of ZIKV has dramatically expanded in recent decades resulting in increasing numbers of infected individuals, and the spike in ZIKV infections has been linked to significant increases in both Guillain-Barré syndrome and microcephaly. While a large number of host proteins have been physically and/or functionally linked to other Flaviviruses, very little is known about the virus-host protein interactions established by ZIKV.

Investigators at the University of Toronto (Canada) generated 10 strains of human cells with each strain expressing one Zika protein. By adding a low molecular weight "epitope" tag to each viral protein they could retrieve these proteins using an antibody that bound to the tag. In addition, they used proximity labeling to identify closely linked viral and human proteins.

Results reported in the July 23, 2018, online edition of the journal Molecular & Cellular Proteomics revealed a set of host cell protein interaction profiles for each of the ten polypeptides encoded in the ZIKV genome. This protein topology network comprised 3033 interactions amongst 1224 unique human polypeptides. This network was enriched in proteins with roles in polypeptide processing and quality control, vesicle trafficking, RNA processing, and lipid metabolism. More than 60% of the network components had been previously implicated in other types of viral infections; the remaining proteins comprised hundreds of new putative ZIKV functional partners.

"A better understanding of these processes will allow us to identify specific vulnerabilities in the virus life cycle where antiviral drugs can be targeted," said senior author Dr. Brian Raught, professor of proteomics and molecular medicine at the University of Toronto.

Related Links:
University of Toronto


Gold Member
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
POC Helicobacter Pylori Test Kit
Hepy Urease Test
New
Laboratory Software
ArtelWare
New
ESR Analyzer
TEST1 2.0
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Hematology

view channel
Image: The microfluidic device for passive separation of platelet-rich plasma from whole blood (Photo courtesy of University of the Basque Country)

Portable and Disposable Device Obtains Platelet-Rich Plasma Without Complex Equipment

Platelet-rich plasma (PRP) plays a crucial role in regenerative medicine due to its ability to accelerate healing and repair tissue. However, obtaining PRP traditionally requires expensive centrifugation... Read more

Immunology

view channel
Image: Prof. Nicholas Schwab has found a biomarker that can predict treatment outcome of glatirameracetate in MS patients (Photo courtesy of Uni MS - M. Ibrahim)

Simple Genetic Testing Could Predict Treatment Success in Multiple Sclerosis Patients

Multiple sclerosis (MS) patients starting therapy often face a choice between interferon beta and glatiramer acetate, two equally established and well-tolerated first-line treatments. Until now, the decision... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.